Reply to Stummer, W.; Thomas, C. Comment on "Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. Cancers 2021, 13, 2540"

Cancers (Basel). 2021 Nov 15;13(22):5705. doi: 10.3390/cancers13225705.

Arthur Hosmann^{1

2}, Matthias Millesi^{1

2}, Lisa I Wadiura^{1

2}, Barbara Kiesel^{1

2}, Petra A Mercea^{1

2}, Mario Mischkulnig^{1

2}, Martin Borkovec¹, Julia Furtner³, Thomas Roetzer^{2

4}, Stefan Wolfsberger^{1

2}, Joanna J Phillips⁵, Anna S Berghoff^{2

6}, Shawn Hervey-Jumper⁷, Mitchel S Berger⁷, Georg Widhalm^{1

2}

¹ Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.
² Comprehensive Cancer Center-Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, 1090 Vienna, Austria.
³ Division of Neuroradiology and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
⁴ Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.
⁵ Department of Pathology, University of California, San Francisco, CA 94143, USA.
⁶ Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
⁷ Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA.

Abstract

We greatly appreciate Dr. Stummer's and Dr. Thomas's interest in our study and their important comments [...].